For something that is only used once a week, a new study finds that the popular weight-loss drug, Ozempic, could be manufactured for much less that what is being put out there. 

Researchers say the weight-loss drug could be profitably produced for less than $5 dollars a month rather than the nearly $1,000 dollars Novo Nordisk charges the US. 

For more, KCBS Radio's Nikki Medoro spoke with Bloomberg's Robert Langreth.